Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes
Status:
Not yet recruiting
Trial end date:
2030-01-01
Target enrollment:
Participant gender:
Summary
A prospective, randomised, open-labelled, multi-center study. The aim of the Steno 1 study is
to test multifactorial intervention in individuals with type 1 diabetes at high risk of CVD
with ambitious treatment targets. We will include 2000 participants. Follow-up is 5 years.
Phase:
N/A
Details
Lead Sponsor:
Steno Diabetes Center Copenhagen
Collaborators:
Aarhus University Hospital Bispebjerg Hospital Herning Hospital Hillerod Hospital, Denmark Hospital of South West Jutland Hvidovre University Hospital Nykøbing Falster County Hospital Randers Regional Hospital Regionshospitalet Horsens Regionshospitalet Silkeborg Regionshospitalet Viborg, Skive Rigshospitalet, Denmark Slagelse Hospital Steno Diabetes Center Nordjylland Steno Diabetes Center Odense Zealand University Hospital